Table: Aska Pharmaceutical Holdings - 9-MTH group results

ASKA Pharmaceutical Holdings

05/02/2024 06:00

Feb 5 (Reuters)- 
             Aska Pharmaceutical Holdings Co., Ltd. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Dec 31, 2023        Dec 31, 2022     Mar 31, 2024 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             48.82               47.26            62.00    
                 (+3.3 pct)          (+7.0 pct)       (+2.5 pct)  
  Operating          5.53                5.04             5.40    
                 (+9.6 pct)          (+7.8 pct)       (+5.7 pct)  
  Recurring          5.63                5.25             5.50    
                 (+7.3 pct)          (+9.5 pct)       (+5.1 pct)  
  Net                6.46                4.18             6.20    
                 (+54.4 pct)         (+2.5 pct)       (+46.3 pct) 
  EPS            228.13 yen          148.19 yen       219.01 yen  
  Ann Div                             16.00 yen        40.00 yen  
  -Q2 div         20.00 yen           8.00 yen                    
  -Q4 div                             8.00 yen         20.00 yen  
  
  NOTE - Aska Pharmaceutical Holdings Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4886.T